SIREN : 442896015
MEDTECH SAS is a French company founded 23 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in MAUGUIO (34130), this company of category ETI shows in 2024 a revenue of 55.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 55 206 214 € | 61 035 064 € | 52 231 862 € | 80 627 260 € | 53 670 185 € | 38 025 449 € | 18 960 872 € | 4 530 627 € | 11 263 798 € | 2 875 921 € |
| Net income | 3 516 001 € | 2 724 103 € | 419 608 € | -3 746 984 € | 2 144 332 € | 249 806 € | -639 629 € | -24 779 564 € | -5 790 261 € | -10 952 105 € |
| EBITDA | 7 009 636 € | 3 995 926 € | -9 465 432 € | 6 593 165 € | 3 648 976 € | 2 601 786 € | -9 575 107 € | -19 461 228 € | -5 540 981 € | -10 837 494 € |
| Net margin | 6.4% | 4.5% | 0.8% | -4.6% | 4.0% | 0.7% | -3.4% | -546.9% | -51.4% | -380.8% |
In 2024, MEDTECH SAS achieves revenue of 55.2 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +44.7%. Slight decline of -10% vs 2023. After deducting consumption (28.1 M€), gross margin stands at 27.1 M€, i.e. a rate of 49%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 7.0 M€, representing 12.7% of revenue. Positive scissor effect: EBITDA margin improves by +6.2 pts, sign of improved operational efficiency. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 3.5 M€, i.e. 6.4% of revenue. This profit can be retained or distributed to shareholders.
55 206 214 €
27 142 036 €
7 009 636 €
5 683 158 €
3 516 001 €
12.7%
The debt ratio (= Financial debt / Equity x 100) stands at 404%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 16%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 5.0 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 8.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
404.102%
15.834%
8.652%
4.952
35.3%
In 2024, the debt ratio of MEDTECH SAS (404.10) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of MEDTECH SAS (15.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of MEDTECH SAS (4.95) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 488.96. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 30.5x. Operating income very largely covers interest expenses: high safety margin.
488.962
30.457
In 2024, the liquidity ratio of MEDTECH SAS (488.96) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2024, the interest coverage of MEDTECH SAS (30.5x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 40 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 9 days. The gap of 31 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 74 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 167 days of revenue, i.e. 25.6 M€ to permanently finance. Over 2016-2024, WCR increased by +100%, requiring additional financing.
25 610 715 €
40 j
9 j
74 j
167 j
Based on 57 transactions of similar company sales
(all years),
the value of MEDTECH SAS is estimated at
14 797 955 €
(range 3 992 597€ - 28 541 622€).
With an EBITDA of 7 009 636€, the sector multiple of 2.5x is applied.
The price/revenue ratio is 0.23x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MEDTECH SAS with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire
The revenue of MEDTECH SAS in 2024 is 55.2 M€.
Yes, MEDTECH SAS generated a net profit of 3.5 M€ in 2024.
The headquarters of MEDTECH SAS is located in MAUGUIO (34130), in the department Herault.
The tax return of MEDTECH SAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MEDTECH SAS operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.